Perceptions of Ophthalmologists Regarding Contemporary Presbyopia Management.
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04733014 |
|
Recruitment Status :
Recruiting
First Posted : February 1, 2021
Last Update Posted : February 1, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease |
|---|
| Presbyopia |
| Study Type : | Observational |
| Estimated Enrollment : | 200 participants |
| Observational Model: | Other |
| Time Perspective: | Prospective |
| Official Title: | Perceptions of Greek Ophthalmologists Regarding Contemporary Presbyopia Management. |
| Actual Study Start Date : | January 7, 2021 |
| Estimated Primary Completion Date : | February 7, 2021 |
| Estimated Study Completion Date : | February 7, 2021 |
- Perceptions on presbyopia [ Time Frame: 1 month ]Greek ophthalmologists' attitudes on contemporary presbyopia management
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 30 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
- Valid license to practice ophthalmology in European Union.
- Adequate literacy of Greek language.
Exclusion Criteria:
- Pediatric ophthalmologist.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04733014
| Contact: Georgios Labiris, MD | 00302551030405 | labiris@usa.net | |
| Contact: Panagiota Ntonti, MD | 00306993188102 | giotado@hotmail.com |
| Greece | |
| Democritus University of Thrace | Recruiting |
| Alexandroupolis, Evros, Greece, 68100 | |
| Contact: Georgios Labiris, MD, PhD 00302551030405 labiris@usa.net | |
| Study Chair: | Georgios Labiris, MD | Democritus University of Thrace |
| Responsible Party: | Georgios Labiris, Associate Professor, Democritus University of Thrace |
| ClinicalTrials.gov Identifier: | NCT04733014 |
| Other Study ID Numbers: |
ES1/Th3/21-1-2021 |
| First Posted: | February 1, 2021 Key Record Dates |
| Last Update Posted: | February 1, 2021 |
| Last Verified: | January 2021 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Presbyopia, disease management, ophthalmologist, attitudes |
|
Presbyopia Refractive Errors Eye Diseases |

